Literature DB >> 22444279

Misregulated RNA processing in amyotrophic lateral sclerosis.

Magdalini Polymenidou1, Clotilde Lagier-Tourenne, Kasey R Hutt, C Frank Bennett, Don W Cleveland, Gene W Yeo.   

Abstract

Amyotrophic lateral sclerosis (ALS) research is undergoing an era of unprecedented discoveries with the identification of new genes as major genetic causes of this disease. These discoveries reinforce the genetic, clinical and pathological overlap between ALS and frontotemporal lobar degeneration (FTLD). Common causes of these diseases include mutations in the RNA/DNA-binding proteins, TDP-43 and FUS/TLS and most recently, hexanucleotide expansions in the C9orf72 gene, discoveries that highlight the overlapping pathogenic mechanisms that trigger ALS and FTLD. TDP-43 and FUS/TLS, both of which participate in several steps of RNA processing, are abnormally aggregated and mislocalized in ALS and FTLD, while the expansion in the C9orf72 pre-mRNA strongly suggests sequestration of one or more RNA binding proteins in pathologic RNA foci. Hence, ALS and FTLD converge in pathogenic pathways disrupting the regulation of RNA processing. This article is part of a Special Issue entitled RNA-Binding Proteins.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22444279      PMCID: PMC3707312          DOI: 10.1016/j.brainres.2012.02.059

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  160 in total

1.  Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis.

Authors:  Stéphanie Millecamps; Philippe Corcia; Cécile Cazeneuve; Séverine Boillée; Danielle Seilhean; Véronique Danel-Brunaud; Nadia Vandenberghe; Pierre-François Pradat; Nadine Le Forestier; Lucette Lacomblez; Gaëlle Bruneteau; William Camu; Alexis Brice; Vincent Meininger; Eric LeGuern; François Salachas
Journal:  Neurobiol Aging       Date:  2011-12-09       Impact factor: 4.673

2.  TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor.

Authors:  Colleen M Dewey; Basar Cenik; Chantelle F Sephton; Daniel R Dries; Paul Mayer; Shannon K Good; Brett A Johnson; Joachim Herz; Gang Yu
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

3.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 4.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

5.  RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS.

Authors:  Shangxi Xiao; Teresa Sanelli; Samar Dib; David Sheps; Joseph Findlater; Juan Bilbao; Julia Keith; Lorne Zinman; Ekaterina Rogaeva; Janice Robertson
Journal:  Mol Cell Neurosci       Date:  2011-03-21       Impact factor: 4.314

6.  Sustained expression of TDP-43 and FUS in motor neurons in rodent's lifetime.

Authors:  Cao Huang; Pedro Yuxing Xia; Hongxia Zhou
Journal:  Int J Biol Sci       Date:  2010-07-04       Impact factor: 6.580

Review 7.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

8.  Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

Authors:  L I Bruijn; M K Houseweart; S Kato; K L Anderson; S D Anderson; E Ohama; A G Reaume; R W Scott; D W Cleveland
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

9.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

10.  TDP-43-mediated neuron loss in vivo requires RNA-binding activity.

Authors:  Aaron Voigt; David Herholz; Fabienne C Fiesel; Kavita Kaur; Daniel Müller; Peter Karsten; Stephanie S Weber; Philipp J Kahle; Till Marquardt; Jörg B Schulz
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

View more
  73 in total

1.  Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.

Authors:  J Gavin Daigle; Karthik Krishnamurthy; Nandini Ramesh; Ian Casci; John Monaghan; Kevin McAvoy; Earl W Godfrey; Dianne C Daniel; Edward M Johnson; Zachary Monahan; Frank Shewmaker; Piera Pasinelli; Udai Bhan Pandey
Journal:  Acta Neuropathol       Date:  2016-01-04       Impact factor: 17.088

Review 2.  C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Authors:  Jennifer S Yokoyama; Daniel W Sirkis; Bruce L Miller
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

3.  The ALS gene FUS regulates synaptic transmission at the Drosophila neuromuscular junction.

Authors:  James B Machamer; Sarah E Collins; Thomas E Lloyd
Journal:  Hum Mol Genet       Date:  2014-02-25       Impact factor: 6.150

Review 4.  Nuclear bodies: the emerging biophysics of nucleoplasmic phases.

Authors:  Lian Zhu; Clifford P Brangwynne
Journal:  Curr Opin Cell Biol       Date:  2015-05-15       Impact factor: 8.382

5.  Conserved DNA methylation combined with differential frontal cortex and cerebellar expression distinguishes C9orf72-associated and sporadic ALS, and implicates SERPINA1 in disease.

Authors:  Mark T W Ebbert; Christian A Ross; Luc J Pregent; Rebecca J Lank; Cheng Zhang; Rebecca B Katzman; Karen Jansen-West; Yuping Song; Edroaldo Lummertz da Rocha; Carla Palmucci; Pamela Desaro; Amelia E Robertson; Ana M Caputo; Dennis W Dickson; Kevin B Boylan; Rosa Rademakers; Tamas Ordog; Hu Li; Veronique V Belzil
Journal:  Acta Neuropathol       Date:  2017-08-14       Impact factor: 17.088

6.  Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System.

Authors:  Fernando J Martinez; Gabriel A Pratt; Eric L Van Nostrand; Ranjan Batra; Stephanie C Huelga; Katannya Kapeli; Peter Freese; Seung J Chun; Karen Ling; Chelsea Gelboin-Burkhart; Layla Fijany; Harrison C Wang; Julia K Nussbacher; Sara M Broski; Hong Joo Kim; Rea Lardelli; Balaji Sundararaman; John P Donohue; Ashkan Javaherian; Jens Lykke-Andersen; Steven Finkbeiner; C Frank Bennett; Manuel Ares; Christopher B Burge; J Paul Taylor; Frank Rigo; Gene W Yeo
Journal:  Neuron       Date:  2016-10-20       Impact factor: 17.173

Review 7.  MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.

Authors:  Paola Rinchetti; Mafalda Rizzuti; Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

8.  Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND).

Authors:  Calixto-Hope Lucas; Mathilde Calvez; Roshni Babu; Amanda Brown
Journal:  Neurosci Lett       Date:  2013-11-08       Impact factor: 3.046

9.  RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.

Authors:  J Gavin Daigle; Nicholas A Lanson; Rebecca B Smith; Ian Casci; Astha Maltare; John Monaghan; Charles D Nichols; Dmitri Kryndushkin; Frank Shewmaker; Udai Bhan Pandey
Journal:  Hum Mol Genet       Date:  2012-12-20       Impact factor: 6.150

Review 10.  Roles for RNA-binding proteins in development and disease.

Authors:  Amy E Brinegar; Thomas A Cooper
Journal:  Brain Res       Date:  2016-03-10       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.